/

Companies / WinSanTor

WinSanTor

United States

WinSanTor develops a drug for peripheral neuropathy

WinSanTor, based in United States, has 2 investors on file, among them Methuselah Fund and Unitleader. Its site was last checked 6 Nov 2026: site answers.

Investors

2 investors on file
InvestorEvidenceType
Methuselah FundPortfolio pageVenture capital
UnitleaderPortfolio pageVenture capital

More from Methuselah Fund

7 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (86%), Industrial & Manufacturing (14%).

See Methuselah Fund's full profile · Who invests alongside it

More from Unitleader

7 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (44%), Real Estate & Construction (33%), Consumer (11%).

See Unitleader's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get WinSanTor and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Methuselah Fund adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/winsantor.com/investors

# also
GET /v1/companies/winsantor.com
GET /v1/companies/winsantor.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing